Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome
Care for patients with human immunodeficiency virus (HIV) infection requires excellence in all aspects of family practice. The family physician’s roles are many: providing patient education to prevent uninfected persons from becoming infected; identifying and instituting early intervention for infected persons; delivering comprehensive care of symptomatic disease including the acquired immunodeficiency syndrome (AIDS); and providing support and care for the family. This broad scope of clinical responsibilities is in an area of clinical medicine where the knowledge base and management strategies are evolving rapidly. New manifestations of HIV disease, diagnostic protocols, and drug recommendations (Table 21.2)1 change on a regular basis. Epidemiologic, social, and community trends also continue to have important effects on clinical care. This chapter provides an overview of important clinical aspects of HIV disease for the family physician.
KeywordsHuman Immunodeficieney Virus Human Immunodeficieney Virus Infection Pneumocystis Carinii Pneumonia Mycobacterium Avium Complex Purify Protein Derivative
Unable to display preview. Download preview PDF.
- 2.Centers for Disease Control; Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 1987;36(Suppl1):1S-15S.Google Scholar
- 3.Guidelines for prevention of transmission of human immunodeficiency virus and hepatitis B virus to health-care and public-safety workers. MMWR 1989;38(Suppl6):1–37.Google Scholar
- 4.Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use. MMWR 1990;39(No. RR-1):1–14.Google Scholar
- 5.Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR 1987;36:509–15.Google Scholar
- 7.Centers for Disease Control. Tuberculosis and human immunodeficiency virus infection: recommendations of the Advisory Committee for the Elimination of Tuberculosis (ACET). MMWR 1989;38:236–8, 243–50.Google Scholar
- 8.Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 1991;40(No. RR-5):27–33.Google Scholar
- 9.Sande MA, Carpenter CC, Cobbs CG, et al. Antiretroviral therapy for adult HIV-infected patients. Recommendations from a state-of-the-art conference. National Institute of Allergy and Infectious Diseases State-of-the-Art Panel on Anti-Retroviral Therapy for Adult HIV-infected Patients. JAMA 1993; 270:2583–9.PubMedCrossRefGoogle Scholar
- 14.Centers for Disease Control. Recommendations for prophylaxis against Pneumocystis carinii pneumonia for adults and adolescents infected with human immunodeficiency virus. MMWR 1992;41(No. RR-4):1–11.Google Scholar
- 15.Recommendations on prophylaxis and therapy for disseminated Mycobacterium avium complex for adults and adolescents infected with human immunodeficiency virus. U.S. Public Health Service Task Force on Prophylaxis and Therapy for Mycrobacterium Avium Complex. MMWR 1993;42(RR-9): 14–20.Google Scholar
- 23.National Institutes of Health—University of California Expert Panel for Corticosteroids as Adjunctive Therapy for Pneumocystis Carinii Pneumonia. Consensus statement on the use of corticosteroids as adjunctive therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 1990;323:1500–4.CrossRefGoogle Scholar
- 27.Centers for Disease Control and Prevention. Recommendations for the use of zidovudine to reduce perinatal transmission of human immunodeficiency virus. MMWR 1994;43(RR-11):1–20.Google Scholar